Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Subcutaneous administration (which bypasses first-pass metabolism and delivers more peptide to target tissues) was not extensively tested in human trials, and this route is what most current research protocols use
6(5): R70
If the patient develops an injection site reaction, a sterile abscess, an allergic response, or a longer term endocrine effect, there is no medical chart, no prescribing clinician, and no insurance pathway
This indicates that further research in this area may be warranted
PubChem compound summary for CID 68816, delta sleep-inducing peptide (DSIP)
The difference
US$ 24.41
US$ 27.76
US$ 21.74
US$ 29.20
US$ 27.19
US$ 29.06
US$ 25.48
US$ 23.15
US$ 28.78
US$ 22.42
